Marsh & McLennan Companies (NYSE:MRSH) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Marsh & McLennan Companies (NYSE:MRSH) had its target price lifted by stock analysts at JPMorgan Chase & Co. from $215.00 to $218.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 14.42% from the stock’s previous close.

A number of other analysts also recently weighed in on MRSH. UBS Group increased their target price on shares of Marsh & McLennan Companies from $216.00 to $222.00 and gave the company a “buy” rating in a research report on Tuesday, October 6th. Weiss Ratings upgraded shares of Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th. Wells Fargo & Company boosted their price target on shares of Marsh & McLennan Companies from $183.00 to $197.00 and gave the stock an “equal weight” rating in a research report on Friday. Bank of America reduced their price objective on shares of Marsh & McLennan Companies from $179.00 to $178.00 and set an “underperform” rating on the stock in a research note on Wednesday, July 15th. Finally, Cantor Fitzgerald increased their price objective on shares of Marsh & McLennan Companies from $212.00 to $218.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $204.42.

Marsh & McLennan Companies Stock Performance

Shares of Marsh & McLennan Companies stock traded up $2.02 on Tuesday, hitting $190.52. The stock had a trading volume of 332,369 shares, compared to its average volume of 2,803,147. The company has a 50 day moving average of $181.14. The stock has a market capitalization of $90.59 billion, a price-to-earnings ratio of 22.79, a P/E/G ratio of 2.61 and a beta of 0.59. Marsh & McLennan Companies has a twelve month low of $156.60 and a twelve month high of $198.49. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.27.

Marsh & McLennan Companies (NYSE:MRSH) last announced its earnings results on Thursday, October 15th. The financial services provider reported $2.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.96 by $0.07. The business had revenue of $6.86 billion during the quarter. Marsh & McLennan Companies had a return on equity of 33.32% and a net margin of 14.20%. The firm’s quarterly revenue was up 8.1% on a year-over-year basis. Equities analysts expect that Marsh & McLennan Companies will post 10.45 earnings per share for the current year.

Insider Activity at Marsh & McLennan Companies

In related news, insider Martin South sold 7,100 shares of the business’s stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the transaction, the insider owned 16,632 shares in the company, valued at $3,159,913.68. The trade was a 29.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Lloyd Yates sold 12,000 shares of the stock in a transaction on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the transaction, the director directly owned 12,001 shares in the company, valued at approximately $2,107,975.65. This represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 19,813 shares of company stock worth $3,597,903 in the last quarter. Company insiders own 0.38% of the company’s stock.

Hedge Funds Weigh In On Marsh & McLennan Companies

Institutional investors and hedge funds have recently made changes to their positions in the stock. Net Worth Advisory Group boosted its stake in Marsh & McLennan Companies by 17.9% during the third quarter. Net Worth Advisory Group now owns 4,735 shares of the financial services provider’s stock worth $814,000 after buying an additional 720 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of Marsh & McLennan Companies by 9.2% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 153,200 shares of the financial services provider’s stock valued at $26,156,000 after acquiring an additional 12,907 shares during the period. Novem Group raised its stake in shares of Marsh & McLennan Companies by 2.5% in the third quarter. Novem Group now owns 6,447 shares of the financial services provider’s stock valued at $1,101,000 after acquiring an additional 155 shares during the period. AA Financial Advisors LLC lifted its holdings in shares of Marsh & McLennan Companies by 3.2% in the 3rd quarter. AA Financial Advisors LLC now owns 5,851 shares of the financial services provider’s stock worth $999,000 after acquiring an additional 183 shares during the last quarter. Finally, Abel Hall LLC bought a new stake in shares of Marsh & McLennan Companies in the 3rd quarter worth about $262,000. Institutional investors own 87.99% of the company’s stock.

About Marsh & McLennan Companies

Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management.

Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions.

Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world.